P11 promoter methylation predicts the antidepressant effect of electroconvulsive therapy

Although electroconvulsive therapy (ECT) is among the most effective treatment options for pharmacoresistant major depressive disorder (MDD), some patients still remain refractory to standard ECT practise. Thus, there is a need for markers reliably predicting ECT non/response. In our study, we have...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Transl Psychiatry
Main Authors: Neyazi, Alexandra, Theilmann, Wiebke, Brandt, Claudia, Rantamäki, Tomi, Matsui, Nobuaki, Rhein, Mathias, Kornhuber, Johannes, Bajbouj, Malek, Sperling, Wolfgang, Bleich, Stefan, Frieling, Helge, Löscher, Wolfgang
Formato: Artigo
Idioma:Inglês
Publicado: Nature Publishing Group UK 2018
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5802592/
https://ncbi.nlm.nih.gov/pubmed/29353887
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41398-017-0077-3
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares